- Staat
- OH
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 03.08.2022
- Impfdatum
- 02.08.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hyperhidrosis
Loss of consciousness
Pallor
Resuscitation
Symptomtext
Patient was given Immunization at 1100 and was stable at time of leaving clinic with mother. Was being walked out per staff due to hx of syncope post injections. When reaching bottom of steps, patient became pale and diaphorectic, and place in a nearby chair. Patient then lost consciousness for approx 30 seconds. Resuscitation efforts effective and heartrate improved and patient stablized.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/s
- Allergien
- NKA
- Vorherige Impfungen
- Experiences syncope with other immunizations
- Staat
- KY
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 19.05.2022
- Impfdatum
- 19.05.2022
- Beginn
- 19.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Hyperhidrosis
Loss of consciousness
Malaise
Nausea
Pallor
Syncope
Urinary incontinence
Symptomtext
Pt lost consciousness while seated about a minute or two after the vaccine was given. Syncope lasted about 30 seconds. Pt also urinated while unconscious. Pt laid down with cold compress. Gave 3 lollipops, 3 glasses of water and granola bar. Pt tried to sit up and then stand twice, but continued to be pale, sweaty, and tired. Pt also reported get nauseous feeling. After about an hour and still not feeling well, EMS was called. Pt transported to hospital about 10:20 am. Mother called me about 1:45pm the same day. She reported after observation, pt was sent home from hospital without treatment. She stated patient feels better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- EMS evaluated upon arrival and transported to hospital 5/19/2022. 98.1 F, 99% O2, 54 HR, BP 110/60
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Pt stated none other than occasional protein powder
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 05.11.2021
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hair colour changes
Presyncope
Symptomtext
presyncopal episode, assisted to ambulate to patient room, transferred to examination table in supine position, was found to be euglcyemic, normocardic, improved s/p 20minutes, given food and cup of water, reported physician's hair looked purple, which resolved following as above
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- headaches
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- nkda
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 25.10.2021
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Fall
Loss of consciousness
Symptomtext
Approximately 10 minutes after receiving all vaccines, patient who had been very nervous became lightheaded and collapsed. She was quickly awakened with stimuls and talking to her and getting her talking. After discussion with parents it was learned that she had been waiting for the shots for school for some time and had not eaten or had anything to drink. Stimulation, observation and support continued for approximately 20 minutes. AT no time did she stop breathing. Patient left for home with her parents at 2 PM.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- At 1:30 PM PERRLA. HRR at 88 BPM, RR 16, Temp 97.6 SAO2 100%.
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- None known
- Andere Medikamente
- None disclosed
- Allergien
- None disclosed
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 31.08.2021
- Impfdatum
- 19.08.2021
- Beginn
- 19.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Loss of consciousness
Syncope
Symptomtext
Mother called last week to report that in the car on the way home from our office the patient report feeling light - headed and did have a syncopal episode with brief (a few seconds) of LOC . No localized site symptoms. No other SX.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Generalized anxiety disorder
- Andere Medikamente
- Sertraline 25mg daily
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 22.10.2021
- Impfdatum
- 20.10.2021
- Beginn
- 21.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dyspnoea
Feeling hot
Malaise
Symptomtext
Patient's brother contacted the Dept. of Health at 10/22/21 @ 0641. He left a message stating that his sister, 'was feeling very sick, with many symptoms'. I contacted the brother, as the parents do not speak the language as their first language, he stated that the patient was at the Dept. of Health on 10/20/21 and recieved vaccinations. On 10/21/21, she began to feel warm (temperature was not taken) and intermittent periods of shortness of breath. Prior to him going to work, she was feeling a little better as their mother had given her some medications, but he did not know what their mother had given her. I contacted the patient, she stated the same, that she was feeling warm (temperature not taken) and having periods of shortness of breath. She further stated that her arms were sore. I told her that her arms could be sore from the injections that she recieved, however the temperature (?) and the shortness of breath could be COVID symptoms. I advised her to go to the emergency room as soon as possible for testing and treatment. She verbalized understanding. I called her brother back, who was at work. I told him that I spoke to his sister and that the symptoms that she was complaining of (temperature? Shortness of breath) could possibly be Covid symptoms and that because she was experiencing shortness of breath, it was advised that she goes to the emergency room as soon as possible for testing and treatment. He verbalized understanding. Unknown if patient went to the emergency room as advised or not.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Unknown
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 19.08.2022
- Impfdatum
- 15.08.2022
- Beginn
- 15.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Injection site pain
Symptomtext
Site: Pain at Injection Site-Mild, Systemic: Dizziness/Lightheadedness-Medium, Additional details: Patient felt dizziness after vaccine. She was monitored. Blood pressure checked (normal). Waited for 15-20 minutes before leaving and felt better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 07.01.2022
- Impfdatum
- 07.01.2022
- Beginn
- 07.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Disorientation
Dizziness
Fall
Headache
Pallor
Symptomtext
14:00 (approx): Patient attempted to stand approx. 1-2 minutes after receiving TDAP, MCV, and HPV vaccines and having a fingerstick hgb (patient was with mother in exam room, unwitnessed by staff) and "almost fell over"- mother caught her and helped lay her on the exam table. Patient did not lose consciousness but felt "woozy". Staff was called to room immediately (this examiner and MA). Patient was somewhat pale and mildly disoriented initially, but awake and able to respond to staff. She was positioned on exam table with feet slightly elevated and a cool compress placed on forehead. Vitals were checked and were as follows: BP 87/52, HR 106, SpO2 98%. Patient was responsive to staff and answered yes/no questions. She was able to drink some apple juice. By 14:10, patient reported feeling better with mild headache only. Pulse was rechecked and was 90. Patient continued to rest lying down until approx. 14:15, at which point mother stated patient felt better and wanted to go home, also mother needed to pick up another child from school. Patient was able to independently get up from exam table and walk out of clinic unassisted. The declined repeat vitals before leaving clinic.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 06.12.2021
- Impfdatum
- 01.12.2021
- Beginn
- 02.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain
Pyrexia
Symptomtext
Father called to report daughter developed fever 101.5 body aches and sore arms 12 hours after the shots. "it was so bad, I almost took her to hospital."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 02.12.2021
- Impfdatum
- 01.12.2021
- Beginn
- 02.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Pruritus
Swelling
Symptomtext
localized swelling, erythema and itching.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 23.11.2021
- Impfdatum
- 09.11.2021
- Beginn
- 09.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Rash
Rash erythematous
Rash pruritic
Scab
Skin exfoliation
Symptomtext
After 30-40 minutes of vaccines administration, patients mother states he began forming a rash to left and right hands and his nose. Pt states he had red itching bumps & noticed peeling/scabbing to the nose ara. Patients mother states she took her soon to the Walk-In Clinic & was prescribed the following medications: Benadryl, Mupirocin, Methyl Prednisone, Triamcinolone.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- Patient referred to Allergist for further evaluation.
- Aktuelle Erkrankungen
- At time of vaccination, none.
- Vorgeschichte
- Functional Murmer
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 12.11.2021
- Impfdatum
- 11.11.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dizziness
Gait disturbance
Magnetic resonance imaging head normal
Symptomtext
Acute onset of dizziness and difficulty walking
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- MRI brain: normal
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- asthma
- Andere Medikamente
- none
- Allergien
- caramel, sweet tarts, bee stings
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 08.10.2021
- Impfdatum
- 08.10.2021
- Beginn
- 08.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Flushing
Hypoaesthesia
Nausea
Pallor
Symptomtext
Client started feeling flushed, dizzy, nauseous, hands were numb and he looked pale. Drink was given, he was monitored and the felt better a few minutes later.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- F
- Eingang
- 24.03.2023
- Impfdatum
- 20.03.2023
- Beginn
- 20.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
expired dose of MENACTRA was inadvertently administered with no reported AE; Initial information was received on 20-Mar-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an adult female patient who stated expired dose of menactra was inadvertently administered with no reported ae after receiving meningococcal A-C-Y-W135 (D CONJ) vaccine [Menactra]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 20-Mar-2023, the patient received 0.5 ml Total (once) dose of suspect meningococcal A-C-Y-W135 (D CONJ) vaccine (Solution for injection) (lot: U7191AA, expiry date: 18-Jan-23), (unknown strength) via intramuscular route in unknown administration site for Immunisation. On 20-Mar-2023 the patient developed a non-serious event of expired dose of menactra was inadvertently administered with no reported ae (expired product administered) same day following the administration of meningococcal A-C-Y-W135 (D CONJ) vaccine. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 17.01.2023
- Impfdatum
- 12.01.2023
- Beginn
- 12.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
Patient received a 3rd dose of Men ACY, W-135 instead of 2nd dose of Men B. No adverse reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Cyanocobalamin 5000 mcg Triamcinolone 0.1% cream
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 06.07.2022
- Impfdatum
- 05.07.2022
- Beginn
- 05.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
12 year old present in clinic with mother for shots today. reviewed immunizations. opted to receive vaccines. scanned vaccines into computer prior to administering. given IM HPV and IM Meningococcal vaccine to left deltoid. IM Tdap given in right deltoid. after administering IM Tdap proceeded to put in lot number and exp dates. the computer would not let me place lot number, RN noticed expiration date 07/01/2022. notified per incident. notified mother of child per incident ( child received vaccine that has expired, informed mother of this and to bring child back in 4 weeks for another Tdap vaccine. mother voiced no complaints, verbalizes understanding
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no known illness at time of vaccination
- Vorgeschichte
- no known health conditions noted
- Andere Medikamente
- no known medications taken
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 0,4
- Geschlecht
- M
- Eingang
- 03.07.2022
- Impfdatum
- 21.06.2022
- Beginn
- 21.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
inappropriate administration of MENACTRA with no reported adverse event; Initial information received on 21-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 5 months old male patient who had an inappropriate administration of menactra with no reported adverse event, while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant vaccines included ROTAVIRUS VACCINE (ROTAVIRUS VACCINE); and DIPHTHERIA VACCINE TOXOID, HEPATITIS B VACCINE RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (PEDIARIX). On 21-Jun-2022, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE( lot U7191AA and expiration date: 18-Jan-2023) at a dose of 0.5ml via intramuscular route in the right anterior thigh as prophylactic vaccination. On 21-JUN-2022, the patient had an inappropriate administration of menactra with no reported adverse event (product administered to patient of inappropriate age)(latency: same day). Action taken:not applicable. It was not reported if the patient received a corrective treatment for the event . At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- ROTAVIRUS VACCINE; PEDIARIX
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- U
- Eingang
- 19.02.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
a temperature excursion due to unknown reasons Temperature reached 1.7C for 6 minutes with no reported adverse event; Initial information received on 14-Feb-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a patient with unknown demographics who had a temperature excursion due to unknown reasons temperature reached 1.7c for 6 minutes with no reported adverse event while receiving vaccines[ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect HIB (PRP/T) VACCINE with unknown dose lot UJ581AAB via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE with unknown dose lot C5788BA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE with unknown dose lot C5829BA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U7191AA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE with unknown dose lot UJ776AA ,UT7347MA via unknown route in unknown administration site. On an unknown date the patient had a temperature excursion due to unknown reasons temperature reached 1.7c for 6 minutes with no reported adverse event (product storage error) (unknown latency) following the administration of HIB. Action taken not applicable. It was not reported if the patient received a corrective treatment for the event (a temperature excursion due to unknown reasons Temperature reached 1.7C for 6 minutes with no reported adverse event). At time of reporting, the outcome was Unknown for the event a temperature excursion due to unknown reasons temperature reached 1.7c for 6 minutes with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 12.01.2022
- Impfdatum
- 11.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Medical assistant accidently gave Dtap instead of Tdap
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Covid 12/13/21
- Vorgeschichte
- none
- Andere Medikamente
- n/a
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 10.01.2022
- Impfdatum
- -
- Beginn
- 03.01.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
The temperature range was from 37.5F to 48.2F; Initial information received on 03-Jan-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a patient with unknown demographics whos temperature range was from 37.5f to 48.2f while receiving vaccines DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC], DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL], MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA], HIB (PRP/T) VACCINE [ActHIB], DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL], DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] and IPV (VERO) [IPOL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect IPV (VERO) lot U1C571M via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot C5774BA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot UJ414AAA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect HIB (PRP/T) VACCINE lot UJ583ABA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U7191AA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot U6900AA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT lot C5779AA via unknown route in unknown administration site. On 03-JAN-2022 the patient developed a non-serious the temperature range was from 37.5f to 48.2f (product storage error) (unknown latency) following the administration of IPV (VERO), , TETANUS AND ACELLULAR PERTUSSIS VACCINE (DAPTACEL), DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE (PENTACEL), HAEMOPHILUS TYPE B (HIB) VACCINE (ActHIB), MENINGOCOCCAL VACCINE (MENACTRA), DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (ADACEL) and DIPHTHERIA AND TETANUS TOXOIDS (TENIVAC) was not applicable. It was not reported if the patient received a corrective treatment for the event (The temperature range was from 37.5F to 48.2F). At time of reporting, the outcome was Unknown for the event the temperature range was from 37.5f to 48.2f. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 16.12.2021
- Impfdatum
- 15.12.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Symptomtext
No symptoms per Mom.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Floxin (ofloxacin) 0.3% otic solution
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 02.12.2021
- Impfdatum
- 22.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Interchange of vaccine products
Product administered to patient of inappropriate age
Symptomtext
Patient that is under 18 years of age was given Moderna vaccine for first COVID vaccination on 10/22/21. Pt presented in clinic on 11/19/21 for 2nd dose and this is when error was discovered. Pt received one dose of Pfizer on 11/19/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- coconuts, peanuts
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 23.11.2021
- Impfdatum
- 19.11.2021
- Beginn
- 21.11.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Dermatitis
Periorbital cellulitis
Symptomtext
Patient was seen and evaluated at urgent care for periorbital cellulitis of right eye and dermatitis. Given prednisone and Keflex.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dermatitis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- F
- Eingang
- 23.11.2021
- Impfdatum
- 12.11.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Symptomtext
MENACTRA WAS inadvertently given subcutaneous instead of the recommended intramuscular route with no reported adverse event; Initial information received on 12-Nov-2021 regarding an unsolicited valid non-serious case from a Pharmacist via non-healthcare professional via Agency (Reference number- 00856094). This case involves adult female patient (unknown age) who received MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] via subcutaneous route (incorrect route of product administration). The patient's medical history, medical treatment, vaccination, concomitant medication and family history were not provided. On 12-Nov-2021, the patient received a 0.5 ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U7191AA and expiry date: 18-Jan-2023) (Frequency: once) via subcutaneous route at an unknown administration site for prophylactic vaccination. It was a case of actual medication error due to inappropriate route of vaccination (same day latency). It was reported "Pharmacist reporting that MENACTRA was inadvertently given subcutaneous instead of the recommended intramuscular route, she is questioning if the dose is valid". At the time of report, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 05.11.2021
- Impfdatum
- 20.09.2021
- Beginn
- 20.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Symptomtext
Administration Error: This was an 11yr old female who receive the 0.3ml of Pfizer COVID Vaccine on : 09/20/21 & 10/18/2021 - Adult series complete on a Pedi pt. No complaints from pt. and no reactions voiced. Parent notified
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Received the following vaccines on the same day as Pfizer: LOT # U6984 / Exp. Date 03/18/2023 / NDC 49281-0400-89 / Left Deltoid. LOT # T029523 / Exp. Date 03/13/2023 / NDC 0006-4121-01/ Left Deltoid. LOT# U719AA /Exp. Date 01/18/2023 / NDC 49281-0589-58.
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 28.10.2021
- Impfdatum
- 15.10.2021
- Beginn
- 15.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient was administered with an extra dose of Menactra with no reported adverse event;Initial information regarding an unsolicited valid non-serious case was received from other health professional via a consumer/non-health care professional via Medical Information (Reference number- 00818817) and transmitted to Sanofi on 19-Oct-2021. This case involves a 17 year old male patient who was received a third dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] [Extra dose administered]. The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included INFLUENZA VACCINE INACT SPLIT 4V (FLUZONE QUADRIVALENT) for prophylactic vaccination. On 15-Oct-2021, the patient received a 0.5 mL third dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U7191AA, expiry: 18-Jan-2023) via intramuscular route in the right deltoid for prophylactic vaccination. It was a case of an actual medication error due to Extra dose administered (latency same day). It was reported "Office manager calling in regards to a third dose of MENACTRA being administered to a patient. Caller would like to know if there are any implications or adverse effects they should be on the lookout for? Patient was administered an extra dose of MENACTRA at an office visit." No other adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- FLUZONE QUADRIVALENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 25.10.2021
- Impfdatum
- 20.10.2021
- Beginn
- 21.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Parotid gland enlargement
Symptomtext
Right sided painless parotid swelling.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Parotid gland enlargement
- Hospital-Tage
- -
- Labordaten
- Physical Exam
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Allergic Rhinitis
- Andere Medikamente
- Singular
- Allergien
- No Known Allergies
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 20.10.2021
- Impfdatum
- 19.10.2021
- Beginn
- 19.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Peripheral swelling
Symptomtext
Left arm swelling and cellulitis, seen in office and prescribed antibiotics and over the counter pain medication
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cellulitis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Apthous ulcer
- Vorgeschichte
- -
- Andere Medikamente
- N/A
- Allergien
- KNDA
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 18.10.2021
- Impfdatum
- 12.10.2021
- Beginn
- 12.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Syringe issue
Underdose
Symptomtext
all the medication did not go into the patient, no AE; While administering Menactra the medication was leaking out between the needle and the syringe because it was not tight enough or connected correctly, no AE; Initial information received on 12-Oct-2021 regarding an unsolicited valid non-serious case from a nurse practitioner and consumer non health care professional via Media Information (under reference number 00808548). This case involves a 16 years old female patient who was administered with MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] and while administering the medication was leaking out between the needle and the syringe because it was not tight enough or connected correctly (syringe issue), and because of which all the medication did not go into the patient (underdose). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. No concomitant medication was given to the patient. On 12-Oct-2021, the patient received 0.5 ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (injection, lot U7191AA and expiration date: 18-Jan-2023)via unknown route in an unknown administration site for prophylactic vaccination. It was a case of an actual medication error due to vaccine underdose and also a case of syringe leak (same day latency). It was reported "The nurse practitioner is reporting that the syringe leaked while she was administering Menactra to a patient and she would like to know if the patient should receive another dose and is that safe and if so when should they receive it and do they have to wait a specific amount of time. The nurse practitioner states that she never had this happen before and she just attempted to administer Menactra to a patient and she noticed that the medication was leaking out between the needle and the syringe because it wasn't tight enough or connected correctly. She states that all the medication didn't go into the patient. She states that she pulled up the medication from the vial without any issues." No laboratory data reported. The nurse will revaccinate the patient. At time of reporting, no adverse event was reported and the outcome was unknown for the reported events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syringe issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -